Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-24 @ 7:43 PM
NCT ID:
NCT02167503
Eligibility Criteria:
Inclusion Criteria:
* Male or female, aged over 30 (inclusive) years of old
* Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months)
* For patients with HBsAg positive, patients should be undergoing anti-viral treatment
* For patients with HBsAg negative, a documented evidence of previous anti-viral treatment should be provided.
* Life expectancy is more than 1 year
* Good treatment compliance.
Exclusion Criteria:
* Patients has a history of diagnosis of hepatocellular carcinoma
* Patients with Child Pugh C
* Coinfected with HCV, HDV and HIV
* Suffering from other serious disease
* Taking part in other clinical trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT02167503
Study Brief:
Protocol Section:
NCT02167503